Biohit Oyj (LTS:0DRP) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 05, 2026)


LTS:0DRP Biohit Oyj LTS:0DRP
79 GF Score
Price €2.74
GF Value €2.79
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Biohit Oyj Float Percentage Of Total Shares Outstanding?

Biohit Oyj LTS:0DRP +3.79% 79 Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 05, 2026. GuruFocus rates LTS:0DRP with a GF Score™ of 79/100 and a GF Value™ of €2.79 (Fairly Valued). The stock has 3 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Biohit Oyj's float shares is 0.00 Mil. Biohit Oyj's total shares outstanding is 15.21 Mil. Biohit Oyj's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Biohit Oyj's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Biohit Oyj's Institutional Ownership is 0.06%.

LTS:0DRP
79GF Score
Biohit Oyj LTS:0DRP
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biohit Oyj Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Biohit Oyj's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/15.21
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
Biohit Oyj (LTS:0DRP) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 05, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Biohit Oyj and its competitors.
Is Biohit Oyj's Float Percentage Of Total Shares Outstanding too high?
Biohit Oyj's current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, Biohit Oyj has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Biohit Oyj's Float Percentage Of Total Shares Outstanding compare to ABT and SYK?
Biohit Oyj's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Devices & Instruments company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Devices & Instruments industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Biohit Oyj and its competitors. Biohit Oyj's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biohit Oyj stock overvalued right now?
Based on GuruFocus' analysis, Biohit Oyj (LTS:0DRP) is currently considered Fairly Valued. The stock's GF Value™ is €2.79, compared to a current price of €2.74 — trading 1.8% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. Biohit Oyj's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Biohit Oyj (LTS:0DRP), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biohit Oyj (LTS:0DRP) Overvalued in 2026?

Based on GuruFocus' analysis, Biohit Oyj stock appears to be undervalued. The current stock price of €2.74 is trading 1.8% below its estimated GF Value™ of €2.79. GuruFocus considers Biohit Oyj to be Fairly Valued.

Key valuation signals for LTS:0DRP:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: €2.79 vs. price of €2.74 (1.8% below fair value)
  • GF Score™: 79/100 with 3 warning signs

No single metric tells the full story. See the LTS:0DRP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biohit Oyj Business Description

Other Exchanges BIOBV:Finland
Address Laippatie 1, Helsinki, FIN, 00880
Biohit Oyj is a globally operating Finnish biotechnology company that develops diagnostic and other health products. Its products include GastroPanel quick test assesses the structure and function of the stomach lining; ColonView quick test is an immunochemical fecal occult blood test (FIT) developed; Acetium capsules protect the stomach lining from carcinogenic acetaldehyde, especially in people with acid-free stomachs. The company's product portfolio consists of diagnostic tests, analysis systems, products binding carcinogenic acetaldehyde into a harmless compound and monoclonal antibodies.
79GF Score

Get the complete analysis for LTS:0DRP

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.74
Price
€2.79
GF Value